Table 1.
Cardiovascular disease | Sample source | No. of patients |
Methods to detect autophagy | Autophagic activity |
Reference |
---|---|---|---|---|---|
Heart failure (DCM) | Ventriculectomy | 27 | EM | Increased | [10] |
Heart failure (unclassified cardiomyopathy) |
Endomyocardial biopsy | 1 | EM | Increased | [1] |
Heart failure (idiopathic DCM) | Explanted hearts | 19 | EM, ubiquitinated proteins | Increased | [12] |
Heart failure (idiopathic DCM, LVAD) | Explanted hearts | 9 | Beclin 1, ATG5, LC3II mRNA and protein level |
Decreased after LVAD |
[13••] |
Glycogen storage disease | Animal model of human disease |
N/A | EM | Decreased | [14•] |
Ischemic heart disease (ischemia–reperfusion) |
Animal model of human disease |
N/A | EM, Beclin 1, LC3, cathepsin D | Increased | [15] |
Anticancer drug-induced cardiomyopathy (doxorubicin) |
Animal model of human disease |
N/A | EM, Beclin 1 | Increased | [16•] |
Anticancer drug-induced cardiomyopathy (bortezomib) |
Animal model of human disease |
N/A | EM, LC3-GFP | Increased | [17•] |
DCM, dilated cardiomyopathy; EM, electron microscopy; LVAD, left ventricular assist device; N/A, not available.